688513.SH
苑东生物
SSE · Healthcare · Biotechnology · CN
CNY 42.91
−5.82%Aug 31, 2026, 09:29 UTC
Yuandong Biologics announced that as of the end of August 2026, it had repurchased 1,386,528 shares (0.7854% of total share capital) for a total amount of 60.7535 million yuan, within its buyback program running from June 4 to September 3, 2026.
Source:Aug 20, 2026, 09:20 UTC
Yuandong Biologics announced its first-half 2026 results: revenue of 659 million yuan, net profit down 4.99% year-on-year.
Source:Aug 20, 2026, 09:20 UTC
Yuandong Biological announced the termination of its biological drug research project, with remaining raised funds of 100 million yuan to be permanently used as working capital.
Source: